FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment
Links shared publicly online about this topic.
- 323total visits
FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment
View full resource at news-medical.net
Tags: Genetic, Cancer, Lymphoma, Hodgkin Lymphoma, Diet and Nutrition, FDA, Genetics
Most Recently Shared on May 2, 2011 at 2:05 pm By:
Oncology News: FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment: Seattle Genetic... http://bit.ly/iOMgRV
Also Shared By:
Seattle Genetics Announces FDA Accepts Brentuximab Vedotin BLAs for Filing and Grants Priority Review for Relapsed or Refractory Hodgkin Lymphoma and Systemic ALCL
drugs.com — “Brentuximab vedotin is a new drug in development for the treatment of Hodgkin's lymphoma and anaplastic large cell lymphoma. Brentuximab vedotin information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on May 12, 2011 at 4:16 am By:
Drugs and Devices OW OW Health
Seattle Genetics Announces FDA Accepts Brentuximab Vedotin BLAs for Filing and Grants Priority Review for ... http://bit.ly/jJ0XLo #drug
Buzzup US News -
buzzup.com — “Buzzup is a user driven social content website. Buzzup news and stories are submitted by our community (that would be you).After you submit content, other people read your submission and vote for what they like best, we call this linking” View full resource at buzzup.com
Most Recently Shared on May 3, 2011 at 10:30 am By:
Genetics News: FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment: Seattle Gene... http://buzzup.com/1q2xs
Advertisement
News-Medical.Net
@NewsMedical
FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment: Seattle Genetics, Inc. announc... http://bit.ly/iOMgRV
1 year ago...